Literature DB >> 2981422

Phosphatase-mediated modulation of actin-myosin interaction in bovine aortic actomyosin and skinned porcine carotid artery.

C Bialojan, J C Rüegg, J Di Salvo.   

Abstract

Since the Ca2+-regulatory mechanism for actin-myosin interaction in smooth muscle involves phosphorylation of the 20,000-Da myosin light chains, it was hypothesized that such interaction should be influenced by myosin phosphatase. Accordingly, we studied the effects of an aortic myosin light-chain phosphatase on Ca1+-dependent actin-myosin interaction in detergent-skinned porcine carotid artery and bovine aortic native actomyosin. In skinned preparations, the aortic phosphatase (16 U/ml) markedly inhibited the rate of isometric contraction in low Ca2+ (6.8 X 10(-7) M) and responsiveness to Ca2+ (force attained with 6.8 X 10(-7) Ca2+/force attained with 1.6 X 10(-6) M Ca2+), whereas relaxation was accelerated. Ca2+-dependent actomyosin ATPase activity and phosphorylation of the light chains were significantly and progressively depressed in the presence of increasing concentrations of phosphatase (0.1-0.9 U/ml). The concentration of Ca2+ (1.1 X 10(-6) M) required for half-maximal activation of either ATPase activity or light-chain phosphorylation increased by 70% in the presence of 0.1 U phosphatase/ml. Neither the maximal rate of Ca2+-sensitive ATP hydrolysis (39 +/- 0.8 nmole/min/mg actomyosin) nor the extent of phosphorylation (0.68 +/- 0.05 mole PO4/mole light chain) was altered at greater than 5 X 10(-6) M Ca2+. ATPase activity was correlated to light-chain phosphorylation under diverse conditions including the presence or absence of 1 microM calmodulin, different concentrations of phosphatase (0-0.9 U/ml), and different concentrations of Ca2+ (10(-8) to 1.25 X 10(-5) M). However, significant phosphorylation was present (20-25% of maximum) in the absence of Ca2+-dependent ATPase activity and only 15% of the maximal rate of ATP hydrolysis was expressed until phosphorylation attained 50% of its maximal value. These findings are consistent with the ordered model of myosin phosphorylation suggested by A. Persechini and D. J. Hartshorne [Science (Washington, DC), 213:1383-285, 1961] (36). They also suggest that myosin phosphatase may participate in modulating actin-myosin interactions in vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981422     DOI: 10.3181/00379727-178-41981

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  7 in total

Review 1.  Vascular smooth muscle contractile elements. Cellular regulation.

Authors:  J T Stull; P J Gallagher; B P Herring; K E Kamm
Journal:  Hypertension       Date:  1991-06       Impact factor: 10.190

2.  A myosin phosphatase modulates contractility in skinned smooth muscle.

Authors:  C Bialojan; J C Rüegg; J DiSalvo
Journal:  Pflugers Arch       Date:  1987-10       Impact factor: 3.657

Review 3.  Modulation of calcium sensitivity in guinea pig taenia coli: skinned fiber studies.

Authors:  J C Rüegg; G Pfitzer
Journal:  Experientia       Date:  1985-08-15

Review 4.  Calcium and smooth muscle contraction.

Authors:  H Jiang; N L Stephens
Journal:  Mol Cell Biochem       Date:  1994-06-15       Impact factor: 3.396

5.  Effects of a protein phosphatase inhibitor, okadaic acid, on membrane currents of isolated guinea-pig cardiac myocytes.

Authors:  J Hescheler; G Mieskes; J C Rüegg; A Takai; W Trautwein
Journal:  Pflugers Arch       Date:  1988-08       Impact factor: 3.657

6.  Protein phosphatase type-1, not type-2A, modulates actin microfilament integrity and myosin light chain phosphorylation in living nonmuscle cells.

Authors:  A Fernandez; D L Brautigan; M Mumby; N J Lamb
Journal:  J Cell Biol       Date:  1990-07       Impact factor: 10.539

7.  Contractile elements and myosin light chain phosphorylation in myometrial tissue from nonpregnant and pregnant women.

Authors:  R A Word; J T Stull; M L Casey; K E Kamm
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.